The SomaLogic Blog

A Mad Hatter’s Question About Correlating Transcriptomics to Proteomics

Understanding the Ramifications of Mutations: Seeing past the trees to the forest

Cancer: The Ultimate Malware

The Guiding Light: How Medical Insights Can Steer Us to Better Health

Before It’s Too Late: Finding and Diagnosing Cancer Correctly

Expensive Doesn’t Always Mean Better: Looking for Ways to Keep Medical Costs Down

More Than Meets The Eye: The Growing Complexity Of Genomics

Regeneration Powers Activated!: Regrowing the Liver from Stem Cells

Moving Beyond Potential

Hot Proteins: Intrinsically Disordered Proteins – A True Source of Super Powers

Goodbye Poke, Hello Pee: Alternatives to Plasma for Heart Disease Diagnosis

When to Trust Reagents: Gotta Have Faith… or Do We?

I Got You: The Strong Bond Between a SOMAmer and Its Protein

Send in the Modifications

Lions and Tigers and Diseases…Oh My!

Hot Proteins: The Prion Collective

Back in the Day

Of Bunnies and Pipettes

Hot Proteins: That Which Endures

Gambling with the Genetic Code

Hot Protein: FUS bucket

I Can See You Clearly Now: Use of Aptamer-Based Therapeutics to Treat Age-Related Macular Degeneration

Do You Know if Your Antibodies were Validated?

Time. Is it on My Side?

The Toll of Aging on the Quest for Gold

Warding off the Theft of Independence and Memories by Alzheimer’s Disease

SOMAmer Sandwich Assays: A New Diagnostic Flavor

Attention to Details

Putting the Pain on Ice: IL-6 SOMAmer Reagent Inhibits Rheumatoid Arthritis

Interleukin-16 is a Novel Protein Biomarker for Rheumatoid Arthritis Disease and Treatment Response

SOMAmer® Reagents: Next-generation Aptamers

Why Pharmaceutical Companies Are Ahead of Academic Scientists on the Topic of Antibody Validation

From deep genotype to deep phenotype

Unbiased Biomarker Discovery in Duchenne Muscular Dystrophy